Cantitate/Preț
Produs

CBT for Those at Risk of a First Episode Psychosis: Evidence-based psychotherapy for people with an 'At Risk Mental State'

Autor Mark van der Gaag, Dorien Nieman, David van den Berg
en Limba Engleză Paperback – 29 apr 2013
Can severe mental illness be prevented by early intervention?
Mental illness is highly prevalent in the general population and has its onset mostly in adolescence and young adulthood. Early intervention usually leads to improved prognosis. This book describes a newly developed, evidence based cognitive behavioural intervention that can be used by clinicians to treat the precursor symptoms of psychosis and other severe mental illness. CBT for those at risk of a First Episode Psychosis offers a detailed new psychotherapy that has been shown to reduce the chance of transition to a first psychotic episode and to improve the chance for recovery. This encompasses:
Psycho-education about prepsychotic symptoms
A review of literature about psychological processes that are known to play a role in the development of psychosis
A comprehensive manual – illustrated by numerous clinical vignettes - that can be used to treat help-seeking subjects with an increased risk of developing psychosis.
Links to online resources and exercises to be used in therapy and education.
A description of the multicentre randomized clinical trial investigating this new psychotherapy.
The vast collective experience and expertise of the authors of this handbook results in an invaluable text for clinicians working in mental health care, as well as students, lecturers and researchers who have an interest in the prevention of schizophrenia and other severe mental illness.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 33171 lei  6-8 săpt.
  Taylor & Francis – 29 apr 2013 33171 lei  6-8 săpt.
Hardback (1) 107937 lei  6-8 săpt.
  Taylor & Francis – 22 apr 2013 107937 lei  6-8 săpt.

Preț: 33171 lei

Preț vechi: 34917 lei
-5% Nou

Puncte Express: 498

Preț estimativ în valută:
6350 6601$ 5265£

Carte tipărită la comandă

Livrare economică 06-20 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780415539685
ISBN-10: 0415539684
Pagini: 240
Ilustrații: 13 black & white illustrations, 18 black & white tables, 13 black & white line drawings
Dimensiuni: 174 x 246 x 15 mm
Greutate: 0.46 kg
Ediția:1
Editura: Taylor & Francis
Colecția Routledge
Locul publicării:Oxford, United Kingdom

Public țintă

Postgraduate, Professional, and Professional Practice & Development

Cuprins

Preface. Introduction. Part I: Theory And Evidence. What is an At-Risk Mental State? How to Identify ARMS Subjects? What are Extraordinary Experiences? Which Cognitive Biases are Associated With ARMS? The Nature of Cognitive Biases. Evidence for Preventing or Postponing a First Episode of Psychosis. Part II: Practice Of CBT For Ultra-High Risk. A Manual for Coping With Extraordinary and Remarkable Experiences. Typical Vignettes of Treatment Cases. Concluding Remarks.

Notă biografică

Mark van der Gaag is Professor of Clinical Psychology at the VU University, Amsterdam, and Head of Psychosis Research, Parnassia Psychiatric Institute, The Hague.
Dorien Nieman is a clinical and research psychologist in the Department of Psychiatry, Academic Medical Center, University of Amsterdam.
David van den Berg is a healthcare psychologist in the Early Detection and Intervention Team, Parnassia, The Hague.

Recenzii

"This book is an important contribution to the treatment of people with a high risk for developing psychosis. The authors succeeded in integrating recent research findings on cognitive biases and the psychology of salience into a cognitive behavioural therapy framework. The authors are excellent researchers and therapists and this effective therapy is described stepwise, making this handbook transparent and easy to read." -Aaron T. Beck, M.D., Professor of Psychiatry, University of Pennsylvania

Descriere

This book describes a new evidence-based cognitive behavioural intervention, to be used by clinicians to treat the precursor symptoms of psychosis.